﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>7</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Tumor necrosis factor-alpha 308 G/A polymorphism and type 2 diabetes mellitus; a systematic review and meta-analysis</ArticleTitle>
    <FirstPage>25</FirstPage>
    <LastPage>31</LastPage>
    <ELocationID EIdType="doi">10.15171/jnp.2018.09</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Hasanpour Dehkordi</LastName>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Dousti</LastName>
      </Author>
      <Author>
        <FirstName>Faezeh</FirstName>
        <LastName>Kiani</LastName>
      </Author>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Zamanian Azodi</LastName>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>RezaeiTavirani</LastName>
      </Author>
      <Author>
        <FirstName>Kourosh</FirstName>
        <LastName>Sayehmir</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jnp.2018.09</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Context: Type 2 diabetes mellitus (T2DM) is a multi-factorial disease with several genetic and environmental factors known to be associated with the disease. Tumor necrosis factoralpha (TNF-α) acts on fat cells associated with increased insulin resistance and obesity and its increase can be associated with the prevalence of T2DM. Previous studies on the relationship between 308 G/A polymorphism in TNF-α and T2DM were not conclusive. The aim of this study was to investigate the association between 308 G/A polymorphism in TNF-α gene and T2DM using a systematic review and meta-analysis. Evidence Acquisitions: In this systematic review we searched all published studies about the association between TNF 308 G/A polymorphism and T2DM through databases such as Scopus, Science direct, PubMed and Google scholar. A fixed or random effect model was used on the basis of heterogeneity. The heterogeneity was assessed using the I2 index. We used STATA software (version 11.2) for data analysis. Results: In 22 selected papers, the total number of T2DM and control subject was 8485 and 8615, respectively. Odds ratios (ORs) with 95% confidence intervals(CI) for the GG genotype polymorphism 308 G/A in total, Asian populations and whites (Caucasian) were estimated as OR=0.98 (95% CI: 0.96-1.00), OR=0.96 (95% CI: 0.93 to 0.99) and OR=1.00 (95% CI: 0.97 to 1.40). The Publication Bias/or heterogeneity was observed in this study. Conclusions: The present investigation have shown that 308 G/A polymorphism GG and GA genotypes in TNF-α gene cannot be considered as predictors of T2DM (P&lt;0.05).</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Diabetes mellitus type 2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">TNF-α</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">308 G/A</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Polymorphism</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>